US90328M1071
US90328M1071
USANA Health Sciences, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 270.87M EUR | 394.19M EUR | 322.44M EUR | 358.85M EUR |
Enterprise Value | 146.97M EUR | 225.63M EUR | 173.69M EUR | 220.12M EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | 38.77x | 264.25x |
Forward P/E | 8.28x | -- | -- | -- |
Price to Sales | 0.3x | 0.43x | 0.35x | 0.53x |
Price to Book | 0.51x | 0.75x | 0.59x | 0.67x |
EV/Revenue | 0.16x | 0.25x | 0.19x | 0.33x |
EV/EBITDA | 1.99x | 3.18x | 2.17x | 4.03x |
Price to FCF (P/FCF) | 5.51x | 24.74x | 108.9x | -- |
EV/FCF | 2.99x | 14.16x | 58.66x | -- |
FCF Yield | 18.14% | 4.04% | 0.92% | -1.16% |